Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_assertion type Assertion NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_head.
- NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_assertion description "[Finally, daily chronic administration of RSVl alleviated hypertension in the experimental model of AngII-induced hypertensive mice, and these effects were accompanied by the activation of AMPK, significantly decreased RhoA activity and phosphorylation levels of MYPT1 and MLC in AngII-treated murine aortic VSMCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_provenance.
- NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_assertion evidence source_evidence_curated NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_provenance.
- NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_assertion SIO_000772 24965170 NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_provenance.
- NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_assertion wasDerivedFrom ctd_human-20150221 NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_provenance.
- NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_assertion wasGeneratedBy ECO_0000218 NP6198.RAzYC3hy-Mu3zOmArunYgpS96G5VuPw3WrR5UL8LNQo8U130_provenance.